de Heer J - Search Results

1

GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations.

Deacon CF, Plamboeck A, Rosenkilde MM, de Heer J, Holst JJ. Deacon CF, et al. Among authors: de heer j. Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E468-75. doi: 10.1152/ajpendo.00577.2005. Epub 2006 Apr 11. Am J Physiol Endocrinol Metab. 2006. PMID: 16608883 Free article.

2

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.

de Heer J, Rasmussen C, Coy DH, Holst JJ. de Heer J, et al. Diabetologia. 2008 Dec;51(12):2263-70. doi: 10.1007/s00125-008-1149-y. Epub 2008 Sep 16. Diabetologia. 2008. PMID: 18795252

3

Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.

de Heer J, Holst JJ. de Heer J, et al. Diabetes. 2007 Feb;56(2):438-43. doi: 10.2337/db06-0738. Diabetes. 2007. PMID: 17259389

4

The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas.

de Heer J, Pedersen J, Orskov C, Holst JJ. de Heer J, et al. Diabetologia. 2007 Oct;50(10):2135-42. doi: 10.1007/s00125-007-0761-6. Epub 2007 Aug 4. Diabetologia. 2007. PMID: 17676310

5

Regulation of glucagon secretion by incretins.

Holst JJ, Christensen M, Lund A, de Heer J, Svendsen B, Kielgast U, Knop FK. Holst JJ, et al. Among authors: de heer j. Diabetes Obes Metab. 2011 Oct;13 Suppl 1:89-94. doi: 10.1111/j.1463-1326.2011.01452.x. Diabetes Obes Metab. 2011. PMID: 21824261 Review.

6

Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade.

Aulinger BA, Bedorf A, Kutscherauer G, de Heer J, Holst JJ, Göke B, Schirra J. Aulinger BA, et al. Among authors: de heer j. Diabetes. 2014 Mar;63(3):1079-92. doi: 10.2337/db13-1455. Epub 2013 Dec 2. Diabetes. 2014. PMID: 24296715 Clinical Trial.

7

Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas?

de Heer J, Göke B. de Heer J, et al. Expert Opin Drug Saf. 2014 Nov;13(11):1469-81. doi: 10.1517/14740338.2014.955013. Epub 2014 Oct 1. Expert Opin Drug Saf. 2014. PMID: 25270593 Review.

8

[Antidiabetic drug therapy in overweight and obese adults with type 2 diabetes].

de Heer J, Parhofer K. de Heer J, et al. MMW Fortschr Med. 2013 Apr 18;155(7):43-6. doi: 10.1007/s15006-013-0432-0. MMW Fortschr Med. 2013. PMID: 23668175 Review. German. No abstract available.

9

Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.

Evans D, de Heer J, Hagemann C, Wendt D, Wolf A, Beisiegel U, Mann WA. Evans D, et al. Among authors: de heer j. Exp Clin Endocrinol Diabetes. 2001;109(3):151-4. doi: 10.1055/s-2001-14838. Exp Clin Endocrinol Diabetes. 2001. PMID: 11409297

10

Prevalence and risk factors of undiagnosed diabetes mellitus among gastroenterological patients: a HbA1c-based single center experience - Prevalence of undiagnosed diabetes in gastroenterological patients.

Fründt T, Schröder N, Hölzemer A, Pinnschmidt H, de Heer J, Behrends BC, Renne T, Lautenbach A, Lohse AW, Schrader J. Fründt T, et al. Among authors: de heer j. Z Gastroenterol. 2022 Sep;60(9):1306-1313. doi: 10.1055/a-1482-8840. Epub 2021 Jun 22. Z Gastroenterol. 2022. PMID: 34157754 English.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters